Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
The Journal of Pathology|December 13, 2006
Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumoursL Khalique, A Ayhan, M E Weale, et al.Oncogenesis|August 16, 2016
Targeting Src in endometriosis-associated ovarian cancerR Manek, E Pakzamir, P Mhawech-Fauceglia, et al.Human Molecular Genetics|January 1, 1994
Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coliS A Gayther, D Wells, S B SenGupta, et al.Cell Proliferation|February 19, 2009
Three-dimensional in vitro cell biology models of ovarian and endometrial cancerB Grun, E Benjamin, J Sinclair, et al.Diseases of the Colon and Rectum|June 20, 2000
Idiopathic slow-transit constipation is not associated with mutations of the RET proto-oncogene or GDNFC H Knowles, S A Gayther, M Scott, et al.The New England Journal of Medicine|April 17, 1997
Contribution of BRCA1 mutations to ovarian cancerJ F Stratton, S A Gayther, P Russell, et al.British Journal of Cancer|August 1, 1996
Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytomaC Eng, K A Foster, C S Healey, et al.Nature Genetics|January 1, 1997
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 geneS A Gayther, J Mangion, P Russell, et al.American Journal of Human Genetics|February 1, 1997
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer populationL S Friedman, S A Gayther, T Kurosaki, et al.British Journal of Cancer|July 4, 1998
Mutation analysis of the c-mos proto-oncogene in human ovarian teratomasK A de Foy, S A Gayther, W H Colledge, et al.Pageof 4